Butterfly Network Inc (BFLY)vsMerck & Company Inc (MRK)
BFLY
Butterfly Network Inc
$6.37
+4.94%
HEALTHCARE · Cap: $1.71B
MRK
Merck & Company Inc
$146.73
-0.14%
HEALTHCARE · Cap: $368.89B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 54566% more annual revenue ($67.38B vs $123.25M). MRK leads profitability with a 3.6% profit margin vs -43.6%. MRK earns a higher WallStSmart Score of 44/100 (D).
BFLY
Avoid27
out of 100
Grade: F
MRK
Hold44
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for BFLY.
Margin of Safety
-72.9%
Fair Value
$84.87
Current Price
$146.73
$61.86 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 51.7% year-over-year
Conservative balance sheet, low leverage
Mega-cap, among the largest globally
Strong operational efficiency at 41.2%
Generating 5.5B in free cash flow
Areas to Watch
Trading at 9.2x book value
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
Trading at 8.6x book value
4.7% revenue growth
ROE of 5.5% — below average capital efficiency
3.6% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : BFLY
The strongest argument for BFLY centers on Revenue Growth, Debt/Equity. Revenue growth of 51.7% demonstrates continued momentum.
Bull Case : MRK
The strongest argument for MRK centers on Market Cap, Operating Margin, Free Cash Flow.
Bear Case : BFLY
The primary concerns for BFLY are Price/Book, EPS Growth, Market Cap.
Bear Case : MRK
The primary concerns for MRK are Price/Book, Revenue Growth, Return on Equity. A P/E of 151.0x leaves little room for execution misses. Thin 3.6% margins leave little buffer for downturns.
Key Dynamics to Monitor
BFLY profiles as a hypergrowth stock while MRK is a value play — different risk/reward profiles.
BFLY carries more volatility with a beta of 2.04 — expect wider price swings.
BFLY is growing revenue faster at 51.7% — sustainability is the question.
MRK generates stronger free cash flow (5.5B), providing more financial flexibility.
Bottom Line
MRK scores higher overall (44/100 vs 27/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Butterfly Network Inc
HEALTHCARE · MEDICAL DEVICES · USA
Butterfly Network, Inc., a digital health company, develops, manufactures, and markets ultrasound imaging solutions in the United States and internationally. The company is headquartered in Guilford, Connecticut.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?